An official document has just confirmed what many feared regarding the safety testing of childhood vaccines...

 

Official Document Confirms What Many Feared About Childhood Vaccine Safety Testing

In a startling revelation, Robert F. Kennedy Jr. (RFK Jr.) has presented evidence that challenges longstanding assurances about the safety testing of childhood vaccines in the United States. For years, Kennedy has maintained that none of the 72 vaccines currently required for school attendance underwent placebo-controlled safety trials before being licensed. This claim was repeatedly dismissed by Dr. Anthony Fauci, who publicly accused Kennedy of spreading misinformation.

A Commission, A Challenge, and Silence

In 2016, President Trump appointed RFK Jr. to chair a commission on vaccine safety. During a White House meeting attended by presidential advisors, Kennedy directly confronted both Dr. Anthony Fauci and Dr. Francis Collins. He demanded proof to counter his assertions, pointing out that Fauci had been calling him a liar for eight years. Fauci reportedly promised to provide the requested documents from Bethesda, but according to Kennedy, nothing ever arrived.

The Lawsuit and the Admission

Frustrated by the lack of response, RFK Jr., with the help of attorney Aaron Siri, filed a lawsuit against Fauci. After a year of legal resistance, the government's representatives finally made a significant admission during a court hearing: they confirmed that Kennedy had been correct all along. No placebo-controlled safety trials had been conducted for those vaccines.

This admission was formally documented in a letter from the Department of Health and Human Services (HHS), now available on the Children's Health Defense (CHD) website and RFK Jr.'s personal site.

A Regulatory Framework Favoring Manufacturers

The absence of such testing, critics argue, is rooted in a regulatory system that heavily favors vaccine manufacturers. Without liability for downstream side effects and no requirement for pre-licensure placebo-controlled safety trials, companies save an estimated quarter of a billion dollars per vaccine. Furthermore, with government mandates requiring these vaccines for 78 million schoolchildren annually, manufacturers face no marketing or advertising costs. For the pharmaceutical industry, it is described as an ideal product.

The Rush to Add New Vaccines

This situation, Kennedy's team argues, has created a gold rush mentality, with a steady push to add new vaccines to the recommended schedule. Many of these target diseases that are non-contagious or have low transmission rates, raising questions about their necessity. Once included in the program, a single vaccine can generate one billion dollars per year for its manufacturer. In some cases, the National Institutes of Health (NIH) even collects royalties on these products.

Today, American children receive 72 doses of 16 different vaccines by the time they reach school age, a number that does not include more recent additions like the HPV vaccine. This proliferation, Kennedy notes, coincided with a dramatic turning point in 1989—the same year that saw an explosion of chronic illnesses among young Americans.

The Rise in Neurological Disorders Since 1989

Since 1989, the prevalence of neurological disorders has risen sharply. Conditions such as Attention Deficit Disorder (ADD), ADHD, Autism Spectrum Disorder (ASD), Tourette syndrome, tics, narcolepsy, and speech delays have become increasingly common—issues that were once rare or virtually unknown in previous generations.

According to data from the Centers for Disease Control and Prevention (CDC), the rate of autism has surged from 1 in 10,000 children in RFK Jr.'s generation to approximately 1 in 34 children today. This dramatic increase raises urgent questions about the role of environmental and medical factors, questions that Kennedy argues have yet to be adequately addressed by public health authorities.